CorMedix Inc.
CRMD
$8.13
-$0.05-0.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 25.99M | 38.60M | 14.02M | 108.56M | 19.83M |
| Total Depreciation and Amortization | 10.54M | 10.54M | 10.43M | 3.79M | 163.00K |
| Total Amortization of Deferred Charges | -- | -- | 398.00K | -- | -- |
| Total Other Non-Cash Items | 12.89M | 25.96M | 39.37M | -55.85M | 2.71M |
| Change in Net Operating Assets | 36.82M | -32.73M | 30.24M | -25.65M | 7.29M |
| Cash from Operations | 86.24M | 42.38M | 94.46M | 30.86M | 29.99M |
| Capital Expenditure | -561.00K | -729.00K | -1.72M | -505.80K | -24.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 1.49M | -310.00M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 3.69M | 3.53M | 19.19M | -20.19M |
| Cash from Investing | -561.00K | 2.97M | 3.30M | -291.32M | -20.21M |
| Total Debt Issued | -- | -- | 0.00 | 150.00M | -- |
| Total Debt Repaid | -177.00K | -135.00K | -138.80K | -49.20K | -- |
| Issuance of Common Stock | 235.00K | 1.18M | 4.62M | 1.33M | 83.49M |
| Repurchase of Common Stock | -6.52M | -12.62M | -257.40K | -464.10K | -247.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -606.00K | -522.00K | -5.64M | -282.40K | -- |
| Cash from Financing | -7.07M | -12.10M | -1.41M | 150.53M | 83.24M |
| Foreign Exchange rate Adjustments | -- | -- | -1.30K | 300.00 | 1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 78.61M | 33.25M | 96.34M | -109.93M | 93.02M |